ProfileGDS4718 / 221970_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 90% 92% 92% 90% 98% 97% 93% 89% 92% 93% 90% 96% 97% 96% 93% 92% 96% 97% 94% 92% 92% 91% 92% 93% 97% 91% 95% 91% 98% 91% 97% 89% 91% 96% 97% 96% 93% 92% 92% 92% 96% 94% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.932993
GSM549102patient 115, normal, homogenized [OPG study]9.1348390
GSM549104patient 119, normal, homogenized [OPG study]9.6848892
GSM549108patient 138, normal, homogenized [OPG study]9.4323792
GSM549119patient 077, normal, homogenized [OPG study]9.1405290
GSM549133patient 032, cancer, homogenized [OPG study]11.199398
GSM549139patient 042, cancer, homogenized [OPG study]11.058997
GSM549099patient 107, normal, homogenized [OPG study]9.8022493
GSM549109patient 139, normal, homogenized [OPG study]9.0063289
GSM549110patient 046, normal, homogenized [OPG study]9.5708492
GSM549114patient 063, normal, homogenized [OPG study]9.9320493
GSM549122patient 082, normal, homogenized [OPG study]9.1825790
GSM549134patient 033, cancer, homogenized [OPG study]10.611396
GSM549136patient 036, cancer, homogenized [OPG study]10.781297
GSM549140patient 044, cancer, homogenized [OPG study]10.623496
GSM549111patient 047, normal, homogenized [OPG study]9.7840793
GSM549113patient 057, normal, homogenized [OPG study]9.7463492
GSM549132patient 031, cancer, homogenized [OPG study]10.358496
GSM549137patient 038, cancer, homogenized [OPG study]10.646497
GSM549142patient 047, cancer, homogenized [OPG study]9.3965594
GSM549100patient 110, normal, homogenized [OPG study]9.479892
GSM549107patient 135, normal, homogenized [OPG study]9.6393892
GSM549115patient 068, normal, homogenized [OPG study]9.5545591
GSM549116patient 072, normal, homogenized [OPG study]9.6334992
GSM549120patient 078, normal, homogenized [OPG study]9.7153893
GSM549131patient 030, cancer, homogenized [OPG study]10.876397
GSM549118patient 074, normal, homogenized [OPG study]9.3924591
GSM549129patient 027, cancer, homogenized [OPG study]10.042295
GSM549123patient 088, normal, homogenized [OPG study]9.436491
GSM549124patient 006, cancer, homogenized [OPG study]10.938698
GSM549126patient 015, cancer, homogenized [OPG study]9.2743491
GSM549128patient 025, cancer, homogenized [OPG study]10.863497
GSM549103patient 117, normal, homogenized [OPG study]8.946889
GSM549117patient 073, normal, homogenized [OPG study]9.5862191
GSM549138patient 041, cancer, homogenized [OPG study]10.652896
GSM549141patient 045, cancer, homogenized [OPG study]11.036597
GSM549130patient 028, cancer, homogenized [OPG study]10.413796
GSM549101patient 111, normal, homogenized [OPG study]9.6810893
GSM549105patient 128, normal, homogenized [OPG study]9.5121192
GSM549106patient 134, normal, homogenized [OPG study]9.7947292
GSM549112patient 048, normal, homogenized [OPG study]9.6510792
GSM549125patient 011, cancer, homogenized [OPG study]10.51396
GSM549127patient 024, cancer, homogenized [OPG study]9.8501594
GSM549135patient 035, cancer, homogenized [OPG study]10.482196